Company Performance - Sensus Healthcare, Inc. closed at $5.51, reflecting a -2.48% change from the previous day, underperforming the S&P 500's gain of 0.4% [1] - Over the past month, shares of Sensus Healthcare, Inc. have increased by 17.22%, while the Medical sector and S&P 500 gained 1.19% and 4.61%, respectively [1] Earnings Forecast - The upcoming earnings release is expected to show an EPS of $0.01, indicating a 90% decline compared to the same quarter last year [2] - Revenue is anticipated to be $8.8 million, representing a 4.76% decrease from the same quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $0.11 per share and revenue of $41.95 million, reflecting a -73.17% change in earnings and a +0.34% change in revenue from the previous year [3] Analyst Sentiment - Recent changes in analyst estimates are crucial as they reflect near-term business trends, with positive revisions indicating confidence in business performance [3] - The Zacks Rank system, which evaluates estimate changes, currently ranks Sensus Healthcare, Inc. at 4 (Sell) [5] Valuation Metrics - Sensus Healthcare, Inc. has a Forward P/E ratio of 51.36, significantly higher than the industry average of 23.12, indicating a premium valuation [6] - The Medical - Instruments industry is ranked 165 in the Zacks Industry Rank, placing it in the bottom 34% of over 250 industries [6]
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note